Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion type Assertion NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_head.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion description "[Furthermore, romidepsin induces expression of genes such as p21 and expression of p75 and NTRK (TrkA) which are more highly expressed in the tumors from NB patients that have a good prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_provenance.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion evidence source_evidence_literature NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_provenance.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion SIO_000772 20404560 NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_provenance.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion wasDerivedFrom befree-20150227 NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_provenance.
- NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_assertion wasGeneratedBy ECO_0000203 NP885017.RAwuXUyPBwX6JHFlOpCQB9BkqRMudA--W2gamj3NXP9Nc130_provenance.